Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-020930
Filing Date
2024-08-07
Accepted
2024-08-07 17:22:35
Documents
2
Period of Report
2024-08-05

Document Format Files

Seq Description Document Type Size
1 form3-08072024_090832.html 3  
1 form3-08072024_090832.xml 3 1739
2 ex24-08072024_090833.htm EX-24 3872
  Complete submission text file 0001415889-24-020930.txt   7044
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Issuer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4560 JINKE ROAD, BLDG. 1, FOURTH FLOOR PUDONG SHANGHAI F4 201210
Business Address
Sandler Alan B. (Reporting) CIK: 0001835966 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39386 | Film No.: 241185102